REVOLUTION BEAUTY GROUP PLC

Director's Dealing • Sep 17, 2025

National Storage Mechanism | Additional information

RNS Number : 5940Z

Revolution Beauty Group PLC

17 September 2025

Revolution Beauty Group plc

Director/PDMR Dealing

Revolution Beauty Group plc (Company), the multi-channel mass beauty brand, has been notified of the following transaction in the Company's shares. This announcement is made in accordance with Article 19(1) of the EU Market Abuse Regulation as incorporated into UK law through the European Union (Withdrawal) Act 2018.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Iain McDonald
2	Reason for the notification
a)	Position/status	Non-Executive Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Revolution Beauty Group plc
b)	LEI	21380083TTJWXK677H17
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of £0.01 each
Identification code	ISIN: GB00BP7L1T61
b)	Nature of the transaction	Purchase of shares
c)	Price(s) and volume(s)
		Price	Volume
		£0.0295	333,334
d)	Aggregated information
- Aggregated volume	n/a
- Price
e)	Date of the transaction	2025-09-16
f)	Place of the transaction	AIMX

For further information, please contact:

Investor Relations

Tom Allsworth, CEO

Neil Catto, CFO

[email protected]

Joint Corporate Brokers

Panmure Liberum (NOMAD):   Edward Thomas / Dru Danford / John More

Tel: +44 (0) 203 100 2222

Zeus:   Ben Robertson / Jordan Warburton

Tel: +44 (0) 161 831 1512

Media enquiries

Headland Consultancy:   Matt Denham / Antonia Pollock

Tel: +44 (0)20 3805 4822

[email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBRGDCDDBDGUL